Christian Brühlmann
Corporate Officer/Principal at ONCONETIX, INC.
Net worth: 28 323 $ as of 30/04/2024
Profile
Christian Brühlmann is the founder and the Chief Business Officer of Proteomedix AG, a company founded in 2010.
He is currently the Chief Strategy Officer at Onconetix, Inc., starting in 2023.
Mr. Brühlmann has a graduate degree from the University of Zurich.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ONCONETIX INC
1.06% | 05/04/2024 | 236,029 ( 1.06% ) | 28 323 $ | 30/04/2024 |
Christian Brühlmann active positions
| Companies | Position | Start |
|---|---|---|
| ONCONETIX, INC. | Corporate Officer/Principal | 01/12/2023 |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Founder | 01/01/2010 |
Training of Christian Brühlmann
| University of Zurich | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Christian Brühlmann
